Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Amorolfine hydrochloride
Drug ID BADD_D00127
Description Amorolfine or amorolfin, is a morpholine antifungal drug that inhibits the fungal enzymes D14 reductase and D7-D8 isomerase. This inhibition affects fungal sterol synthesis pathways, depleting ergosterol and causing ignosterol to accumulate in the fungal cytoplasmic cell membranes. Amorolfine is marketed as Curanail, Loceryl, Locetar, and Odenil. It is available in the form of a 5% amorolfine nail lacquer used to treat onychomycosis (fungal infection of the toe- and fingernails). Amorolfine 5% nail lacquer in once or twice weekly applications is 60-71% effective in treating toenail onychomycosis; complete cure rates three months after stopping treatment (after six months of treatment) were 38-46%. However, full experimental details of these trials were not available and since they were first reported in 1992 there have been no subsequent trials. It is a topical solution for the treatment of toenail infections. Systemic treatments may be considered more effective. It is approved for sale over the counter in Australia and the UK (recently re-classified to over the counter status), and is approved for the treatment of toenail fungus by prescription in other countries. It is not approved for the treatment of onychomycosis in the United States or Canada.
Indications and Usage Not Available
Marketing Status Not Available
ATC Code D01AE16
DrugBank ID DB09056
KEGG ID D01720
MeSH ID C038974
PubChem ID 54259
TTD Drug ID D0QC3M
NDC Product Code Not Available
Synonyms amorolfine | Loceryl | Locéryl | Locetar | Ro 14-4767-002 | Ro-14-4767-002 | amorolfin hydrochloride | amorolfine hydrochloride | Odenil
Chemical Information
Molecular Formula C21H36ClNO
CAS Registry Number 78613-38-4
SMILES CCC(C)(C)C1=CC=C(C=C1)CC(C)CN2CC(OC(C2)C)C.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Erythema23.03.06.001--Not Available
Nail discolouration23.02.05.001--
Nail disorder23.02.05.002--
Pruritus23.03.12.001--
Onychoclasis23.02.05.005--Not Available
Type IV hypersensitivity reaction10.01.03.022--Not Available
The 1th Page    1    Total 1 Pages